Bibliography
Export 22 results:
Filters: Author is First,M. R. and Keyword is Adult [Clear All Filters]
Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study. Clin Transplant. 2005;19(1):102-9.
Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc. 2005;37(2):954-5.
Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry. Transplantation. 2004;78(11):1676-82.
Posttransplant malignancy. Prog Transplant. 2004;14(3):193-200.
Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma. Transplantation. 2004;78(7):972-7.
De novo breast cancer in renal transplant recipients. Transplant Proc. 2002;34(5):1778-9.
De novo sarcomas in solid organ transplant recipients. Transplant Proc. 2002;34(5):1786-7.
Gastric cancer in transplant recipients: detection of malignancy [correction of malignacy] by aggressive endoscopy. Transplant Proc. 2002;34(5):1784-5.
Immunosuppression and Merkel cell cancer. Transplant Proc. 2002;34(5):1780-1.
Transplantation without steroids. Transplant Proc. 2002;34(6):2076-8.
Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry. Transplant Proc. 2001;33(40762):3660-1.
Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation. 1999;68(11):1717-21.
Clinical course of malignancies in renal transplant recipients. Cancer. 1993;72(7):2186-9.
Efficacy of induction therapy in cadaveric renal transplantation comparing rabbit antithymocyte serum and Minnesota antilymphoblast globulin. Transplant Proc. 1991;23(1 Pt 2):1253-5.
Recent contributions to transplantation at the University of Cincinnati. Clin Transpl. 1991:159-78.
Prednisone withdrawal in HLA-identical living related donor transplant recipients. Transplant Proc. 1989;21(1 Pt 2):1617-9.
Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients. Am J Kidney Dis. 1989;14(5 Suppl 2):14-8.
Current experience with renal transplantation in older patients. Am J Kidney Dis. 1988;12(6):516-23.
Development and incidence of cancer following cyclosporine therapy. Transplant Proc. 1986;18(2 Suppl 1):210-5.